MedTrace Logo

Novel Topical Treatment of Hand Dermatitis (Eczema)

NCT00614289 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-03-08

No results posted yet for this study

Summary

This study is designed as a prospective, randomized, double-blind right/left comparison of Epikeia coatings to improve hand dermatitis.

Conditions

  • Contact Dermatitis
  • Eczema, Contact

Interventions

DEVICE

Epikeia Coatings

Topical skin coating

Sponsors & Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Biomedical Development Corporation

    lead INDUSTRY

Principal Investigators

  • Adelaide A. Hebert, MD · University of Texas Health Science Center, Department of Dermatoloy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00614289 on ClinicalTrials.gov